Trademark: 79103969
Word
CITELINE
Status
Registered
Status Code
708
Status Date
Friday, January 12, 2024
Serial Number
79103969
Registration Number
4762279
Registration Date
Tuesday, June 30, 2015
Mark Type
4000
Filing Date
Thursday, March 31, 2011
Published for Opposition
Tuesday, April 14, 2015

Trademark Owner History

Classifications
41 Education services, namely, providing educational seminars, [ conferences, classes and workshops ] in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; [ Training services in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; entertainment and recreational services, namely, sporting and cultural events, training and educational conferences, courses, seminars and exhibitions in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Publishing and issuing of scientific papers in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] Electronic publishing services, namely, publication of text and graphic works of others online featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare [ ; the provision of news online in the nature of news agencies, namely, gathering and dissemination of news; Nondownloadable electronic publications in the nature of journals, newsletters, reports, and directories in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare via the Internet ]
9 [ Apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, prerecorded magnetic data carriers featuring information and data in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; blank recording optical discs; pre-recorded CDs, video tapes, laser disks and DVDs featuring information in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare and manuals in electronic format sold as a unit; computer software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] downloadable electronic publications in the nature of [ newsletters, ] reports, [ directories and bulletins ] in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare from databases or the internet; downloadable electronic publications and information, namely, [ newsletters, ] reports, [ directories and bulletins ] in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare provided on-line from databases or the internet; [ computer programs featuring programming languages in electronic form for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; prerecorded magnetic, electronic or optical data carriers featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] electronic publications, namely, instruction manuals recorded on computer media relating to use of computers and to data, all recorded magnetically, optically or electronically; magnetic, optical and electronic data recording apparatus for recording of sound, images or data
16 [ Paper and cardboard; goods made from paper or cardboard not included in other classes, namely, boxes, cartons, storage containers, and packaging containers; printed materials, namely, journals, newsletters, reports, and directories featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; printed instructional materials in the field of computer software and programmes; book-binding material; photographs; stationery; printed instructional, educational, and teaching materials in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare ]
44 Medical services; advisory medical services and the provision of medical information; dentistry services; advisory medical services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; providing medical information, consultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare relating to all the aforesaid services provided on-line
42 [ Medical services; advisory medical services and the provision of medical information; dentistry services; advisory medical services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; providing medical information, consultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services ] in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare [ relating to all the aforesaid services provided on-line]
CITE LINE

Trademark Events
Mar 7, 2024
Change Of Owner Received From Ib
Jan 12, 2024
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Jan 12, 2024
Case Assigned To Post Registration Paralegal
Jan 12, 2024
Post Registration Action Mailed No Response Required
Jan 12, 2024
Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.
Jan 12, 2024
Registered - Sec. 7 Request Abandoned
Jan 10, 2024
Case Assigned To Post Registration Paralegal
Mar 24, 2023
Invalidation Reviewed - No Action Required By Office
Feb 25, 2023
Change Of Owner Received From Ib
Feb 7, 2023
Partial Invalidation Of Reg Ext Protection Created
Dec 6, 2022
Teas Response To Office Action-Post Reg Received
Nov 30, 2022
Teas Section 7 Request Received
Jun 7, 2022
Post Registration Action Mailed - Sec. 71 & 15
Jun 6, 2022
Case Assigned To Post Registration Paralegal
Dec 29, 2021
Teas Section 71 & 15 Received
May 20, 2021
International Registration Renewed
Jun 30, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jan 26, 2017
Change Of Name/Address Rec'd From Ib
Jan 5, 2017
Change Of Owner Received From Ib
Aug 4, 2016
New Representative At Ib Received
Nov 17, 2015
Final Decision Transaction Processed By Ib
Oct 26, 2015
Final Disposition Notice Sent To Ib
Oct 26, 2015
Final Disposition Processed
Sep 30, 2015
Final Disposition Notice Created, To Be Sent To Ib
Jun 30, 2015
Registered-Principal Register
Apr 14, 2015
Official Gazette Publication Confirmation E-Mailed
Apr 14, 2015
Published For Opposition
Apr 10, 2015
Notification Processed By Ib
Mar 25, 2015
Notification Of Possible Opposition Sent To Ib
Mar 25, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 25, 2015
Notification Of Notice Of Publication E-Mailed
Mar 6, 2015
Law Office Publication Review Completed
Mar 5, 2015
Approved For Pub - Principal Register
Jan 20, 2015
Assigned To Lie
Oct 16, 2014
Change Of Owner Received From Ib
Jul 16, 2014
Notification Of Letter Of Suspension E-Mailed
Jul 16, 2014
Letter Of Suspension E-Mailed
Jul 16, 2014
Suspension Letter Written
Jul 8, 2014
Teas/Email Correspondence Entered
Jul 8, 2014
Correspondence Received In Law Office
Jul 8, 2014
Teas Request For Reconsideration Received
Jan 9, 2014
Notification Of Final Refusal Emailed
Jan 9, 2014
Final Refusal E-Mailed
Jan 9, 2014
Final Refusal Written
Dec 23, 2013
Teas/Email Correspondence Entered
Dec 23, 2013
Correspondence Received In Law Office
Dec 23, 2013
Teas Response To Office Action Received
Jun 28, 2013
Notification Of Non-Final Action E-Mailed
Jun 28, 2013
Non-Final Action E-Mailed
Jun 28, 2013
Non-Final Action Written
May 28, 2013
Teas/Email Correspondence Entered
May 28, 2013
Correspondence Received In Law Office
May 28, 2013
Teas Response To Office Action Received
Apr 20, 2013
Notification Of Possible Opposition - Processed By Ib
Apr 5, 2013
New Representative At Ib Received
Apr 3, 2013
Notification Of Possible Opposition Sent To Ib
Apr 3, 2013
Notification Of Possible Opposition Created, To Be Sent To Ib
Nov 27, 2012
Notification Of Non-Final Action E-Mailed
Nov 27, 2012
Non-Final Action E-Mailed
Nov 27, 2012
Non-Final Action Written
Nov 1, 2012
Teas/Email Correspondence Entered
Oct 31, 2012
Correspondence Received In Law Office
Oct 31, 2012
Teas Response To Suspension Inquiry Received
Jun 8, 2012
Notification Of Letter Of Suspension E-Mailed
Jun 8, 2012
Letter Of Suspension E-Mailed
Jun 8, 2012
Suspension Letter Written
Jun 6, 2012
Limitation From The Ib Examined, No Action Is Needed
May 25, 2012
Attorney/Dom.Rep.Revoked And/Or Appointed
May 25, 2012
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 9, 2012
Teas/Email Correspondence Entered
May 9, 2012
Correspondence Received In Law Office
May 9, 2012
Teas Response To Office Action Received
May 4, 2012
Limitation Of Goods Received From Ib
Dec 19, 2011
Refusal Processed By Ib
Nov 27, 2011
Refusal Processed By Ib
Nov 11, 2011
Application Filing Receipt Mailed
Nov 10, 2011
Non-Final Action Mailed - Refusal Sent To Ib
Nov 10, 2011
Non-Final Action Mailed - Refusal Sent To Ib
Nov 10, 2011
Refusal Processed By Mpu
Nov 10, 2011
Non-Final Action (Ib Refusal) Prepared For Review
Nov 9, 2011
Non-Final Action Written
Nov 8, 2011
Refusal Processed By Mpu
Nov 8, 2011
Non-Final Action (Ib Refusal) Prepared For Review
Nov 7, 2011
Non-Final Action Written
Nov 7, 2011
Assigned To Examiner
Nov 7, 2011
New Application Office Supplied Data Entered
Nov 3, 2011
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24